We are live on
!
Find out more
Viking Global Investors Portfolio holdings
AUM
$35.7B
1-Year Est. Return
21.3%
This Fund
S&P 500
This Quarter
Est. Return
-6.26%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$26.1B
AUM Growth
-$377M
(-1.4%)
Cap. Flow
+$1.92B
Cap. Flow
% of AUM
7.35%
Top 10 Holdings %
Top 10 Hldgs %
51.63%
Holding
78
New
23
Increased
19
Reduced
20
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$1.21B |
| 2 |
Labcorp
LH
|
+$608M |
| 3 |
Elevance Health
ELV
|
+$602M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$575M |
| 5 |
Netflix
NFLX
|
+$485M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$661M |
| 2 |
MetLife
MET
|
+$660M |
| 3 |
Cigna
CI
|
+$472M |
| 4 |
Mohawk Industries
MHK
|
+$462M |
| 5 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$263M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.42% |
| 2 | Consumer Discretionary | 14.42% |
| 3 | Communication Services | 11.15% |
| 4 | Financials | 8.97% |
| 5 | Materials | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
51
DELISTED
Clovis Oncology, Inc.
CLVS
| $76.9M | 0.29% |
+836,332
| New | +$72.4M |
|
|
BLUE
52
DELISTED
bluebird bio
BLUE
| $52.7M | 0.2% |
+47,521
| New | +$86.7M |
|
53
Advance Auto Parts
AAP
$3.36B
| $40M | 0.15% |
+211,256
| New | +$36.6M |
|
54
Amgen
AMGN
$226B
| $31.9M | 0.12% |
+230,298
| New | +$36.3M |
|
55
Boston Scientific
BSX
$73.1B
| $26.5M | 0.1% |
+1,611,935
| New | +$27.6M |
|
56
Deere & Co
DE
$164B
| $15.9M | 0.06% |
214,772
-45,203
| -17% | -$3.98M |
|
|
WLL
57
DELISTED
Whiting Petroleum Corporation
WLL
| $15.8M | 0.06% |
3,438
-25,407
| -88% | -$157M |
|
|
CHK
58
DELISTED
Chesapeake Energy Corporation
CHK
| $14.2M | 0.05% |
+9,704
| New | +$16.5M |
|
59
ProQR Therapeutics
PRQR
$255M
| $8.4M | 0.03% |
576,632
-18,675
| -3% | -$313K |
|
60
Agilent Technologies
A
$42B
| $7.51M | 0.03% |
+218,650
| New | +$8.27M |
|
61
Energy Transfer Partners
ET
$70.9B
| $2.61M | 0.01% |
+125,250
| New | +$3.54M |
|
62
Dentsply Sirona
XRAY
$2.32B
| $2.53M | 0.01% |
+50,000
| New | +$2.66M |
|
63
Aon
AON
$75.7B
| – | – |
-1,912,946
| Closed | -$191M |
|
64
Ball Corp
BALL
$16.6B
| – | – |
-3,665,578
| Closed | -$129M |
|
65
Baidu
BIDU
$37.1B
| – | – |
-1,285,451
| Closed | -$256M |
|
66
Biogen
BIIB
$30.6B
| – | – |
-513,444
| Closed | -$207M |
|
67
Avis
CAR
$4.9B
| – | – |
-4,320,377
| Closed | -$190M |
|
|
68
Cigna
CI
$73.6B
| – | – |
-2,914,815
| Closed | -$472M |
|
69
Capital One
COF
$134B
| – | – |
-1,162,593
| Closed | -$102M |
|
70
Cooper Companies
COO
$14.9B
| – | – |
-1,094,252
| Closed | -$48.7M |
|
|
ESPR
71
DELISTED
Esperion Therapeutics
ESPR
| – | – |
-1,395,107
| Closed | -$114M |
|
|
72
MetLife
MET
$61.7B
| – | – |
-13,217,561
| Closed | -$660M |
|
73
NXP Semiconductors
NXPI
$58.9B
| – | – |
-1,418,054
| Closed | -$139M |
|
74
Thermo Fisher Scientific
TMO
$222B
| – | – |
-207,527
| Closed | -$26.9M |
|
75
Universal Health Services
UHS
$10.2B
| – | – |
-1,220,743
| Closed | -$173M |
|
Similar funds
SAM
VIA
Viking Global Investors's Q3 2015 Portfolio in Review
As of Q3 2015, Viking Global Investors held 78 positions worth $26.1B, down 1.4% from $26.5B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Viking Global Investors deployed $1.92B of net new capital in Q3 2015, opening 23 new positions and adding to 19 existing holdings. Its largest new stake was BROADCOM CORP CL-A: 23,568,995 shares worth $1.21B.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 38% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Illumina, an estimated $661M trimmed.
- Viking Global Investors's largest Q3 2015 buy was BROADCOM CORP CL-A: 23,568,995 shares worth $1.21B.
- Viking Global Investors added most to Elevance Health in Q3 2015, an estimated $602M increase.
- Viking Global Investors's biggest Q3 2015 reduction was Illumina, cutting an estimated $661M.
- Viking Global Investors fully exited MetLife in Q3 2015, selling an estimated $660M.
- Viking Global Investors's ten largest holdings make up 52% of its $26.1B portfolio in Q3 2015.
- Viking Global Investors opened 23 new positions and closed 16 in Q3 2015.
- Viking Global Investors's portfolio value fell 1.4% quarter-over-quarter to $26.1B.
Based on Viking Global Investors's 13F filing for Q3 2015, filed 16 Nov 2015.